Aug. 4, 2020
A UNC-led partnership will receive $40 million in U.S. Department of Energy funding to accelerate fundamental research of the production of fuels from sunlight. The North Carolina-based Center for Hybrid Approaches in Solar Energy to...Read More
July 21, 2020
For the first time in the University’s history, annual new awards for research have exceeded the $1 billion mark. The record amount in new grants, contracts and awards received in the fiscal year that concluded...Read More
Dr. Myron S. Cohen, an acclaimed physician and researcher who has spent the past three decades studying the transmission and prevention of HIV/AIDS, will speak at Commencement on Dec. 16.
Chancellor Holden Thorp ’86 chose Cohen, the J. Herbert Bate Distinguished Professor of medicine, microbiology and immunology and public health, in consultation with the Commencement Speaker Selection Committee, which includes students and faculty. The selection continues Carolina’s tradition of faculty speakers at December Commencement.
“Through his internationally recognized scholarship, Mike Cohen epitomizes the vast power of a research university and its people to help tackle the world’s greatest problems,” Thorp said. “His work has helped fundamentally change prevention strategies and the search for a cure as part of the global fight against AIDS.”
Cohen joined the UNC faculty in 1980 — the same year that AIDS was first identified — and was one of the first to recognize that any attempt to stem the AIDS epidemic would require an international program targeting improved care, treatment and research in resource-poor countries such as Malawi, China, the Democratic Republic of Congo, South Africa and Russia, as well as the United States.
Cohen’s team of researchers at Carolina developed sensitive assays to measure the concentration of HIV in bodily fluids and was among the first to demonstrate that the presence of other sexually transmitted diseases can increase the likelihood of HIV transmission.
Their research provided the scientific foundation for the Center for Disease Control’s 2005 strategic plan for HIV prevention and led the National Institutes of Health to tap Carolina to help develop a safe and effective vaccine against HIV/AIDS.
As the architect and principal investigator of the multinational National Institutes of Health HIV Prevention Trials Network, Cohen was instrumental in showing that antiretroviral treatment prevents the sexual transmission of HIV-1. This work was recognized by Science Magazine as the “Breakthrough of the Year” in 2011.
In April, he received the top honor of the inaugural Clinical Research Forum Top 10 Clinical Research Achievement Awards. The winning projects represented compelling examples of the scientific innovation that results from the nation’s investment in clinical research that can benefit human health and welfare.
A University faculty member for more than 30 years, Cohen’s titles include associate vice chancellor for global health and director of the Institute for Global Health and Infectious Diseases. He earned his undergraduate degree from the University of Illinois and his medical degree from Rush Medical College in Chicago.